Could starting an insulin pump at home be safe and better for patients?

NCT ID NCT07492992

Not yet recruiting Disease control Sponsor: Air Liquide Healthcare Spain Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether people with type 1 diabetes can safely start using an advanced hybrid closed-loop insulin pump system at home instead of in the hospital. Researchers will track blood sugar levels, quality of life, and costs over 12 months in 80 adults. Participants receive online training, a home visit from a nurse, and remote monitoring every two weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Tandem with Control-IQ hybrid closed-loop insulin pump system
What this could lead to: If successful, this could show that starting the insulin pump at home is safe and effective, potentially reducing hospital visits and improving quality of life for people with type 1 diabetes.
What could go wrong: This is an observational study with only 80 participants, so results may not apply to everyone. The home setup might not be as safe as hospital-based initiation, and technical issues could arise.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 1 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus type 1 diabetes mellitus 1

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES MELLITUS, TYPE 1

Contacts and locations

Locations

Hospital General Universitario Santa Lucía

Cartagena, Murcia, 30202, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.